Hospitals Can Now Purchase Remdesivir, Extending Logistics Cold Chain Closer to Patients

Hospitals Can Now Purchase Remdesivir, Extending Logistics Cold Chain Closer to Patients

The US Food and Drug Administrations (FDA) continues to provide guidance regarding the testing, treatment and information on the COVID-19 virus. This recent change as of October 1st, 2020 allows hospitals authorization to purchase the drug Remdesivir, an antiviral that has been used on COVID-19 patients, directly from the drug's distributor. 

This latest change allows the temperature controlled packaging manufacturers within the cold chain logistics sector the opportunity to provide products and services that will support the availability and distribution of the commercial drug treatments to the patients within the US hospitals.

Read the full article